In BCP-ALL, Lck also seems to function downstream of the IL-7R to activate STAT5 and its downstream target genes cMYC and CCND2, as an Lck inhibitor attenuated STAT5 signaling in leukemic cells (Figure 2) [88]. Here, LCK is linked to acute lymphoblastic leukemia.